Search results for " Ventricular"

showing 10 items of 376 documents

Speckle myocardial imaging modalities for early detection of myocardial impairment in isolated left ventricular non-compaction

2009

Objective To examine the hypothesis that speckle myocardial imaging (SMI) modalities, including longitudinal, radial and circumferential systolic (s) and diastolic (d) myocardial velocity imaging, displacement (D), strain rate (SR) and strain (S), as well as left ventricular (LV) rotation/torsion are sensitive for detecting early myocardial dysfunction in isolated LV non-compaction (iLVNC). Design and results Twenty patients with iLVNC diagnosed by cardiac magnetic resonance (15) or echocardiography (5) were included. Patients were divided into two groups: ejection fraction (EF)>50% (n=10) and EF≤50% (n=10). Standard measures of systolic and diastolic function including pulsed wave tissue D…

AdultMalemedicine.medical_specialtyDiastoleDoppler imagingechocardiography cardiomyopathy.ArticleVentricular Dysfunction LeftYoung AdultSpeckle patternInternal medicinemedicineHumansUltrasonographyObserver VariationIsolated Noncompaction of the Ventricular MyocardiumEjection fractionmedicine.diagnostic_testbusiness.industryArea under the curveReproducibility of ResultsStroke VolumeMagnetic resonance imagingStroke volumeMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareMagnetic Resonance ImagingCirculatory systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesHeart
researchProduct

PQ Interval in Patients With Fabry Disease

2010

Fabry disease (FD) is an X-chromosomal inherited lysosomal storage disease resulting in intracellular storage of globotriaosylceramide. Cardiac involvement is most frequently manifested as left ventricular hypertrophy. However, patients with FD may also have from various conduction abnormalities particularly affecting atrioventricular (AV) conduction. The present study was designed to analyze primarily AV conduction abnormalities on baseline electrocardiograms of patients with FD and to investigate the correlation with echocardiographic findings. Electrocardiograms at rest of 207 patients with FD were compared to echocardiograms. PQ-interval shortening and first-degree AV block could be fou…

AdultMalemedicine.medical_specialtyDiastoleLeft ventricular hypertrophyMuscle hypertrophyCohort StudiesElectrocardiographyYoung AdultInternal medicinePrevalencemedicineHumanscardiovascular diseasesPR intervalAtrioventricular Blockmedicine.diagnostic_testVascular diseasebusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseFabry diseaseEchocardiography DopplerElectrocardiographic FindingCardiologyFabry DiseaseFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe American Journal of Cardiology
researchProduct

Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy

1998

Between 1988 and 1992, 565 type 2 diabetic patients were examined for nephropathy and diabetes-associated diseases during hospital treatment. Stages of nephropathy were defined as no clinical sign of nephropathy (N = 280), microalbuminuria (N = 38), overt proteinuria (N = 105), impaired renal function (N = 55), and chronic dialysis therapy (N = 87). In dialyzed patients, HbA1c averaged 6.8%, and, in the other groups, HbA1c was between 7.6% and 8.3% (normal range, 3.8%-6.1%). Cataract was not associated with the severity of nephropathy. Stroke was most common in the stage of renal insufficiency (34%). The following complications, as found in medical history or as current event, showed a sign…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMyocardial InfarctionBlood PressureGastroenterologyNephropathyCohort StudiesDiabetic nephropathyEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansCarotid StenosisDiabetic NephropathiesRenal replacement therapyAgedDiabetic RetinopathyProteinuriabusiness.industryMiddle Agedmedicine.diseaseSurgeryRenal Replacement TherapyCerebrovascular DisordersProteinuriaDiabetes Mellitus Type 2HypertensionAlbuminuriaFemaleHypertrophy Left VentricularMicroalbuminuriaMorbiditymedicine.symptombusinessKidney diseaseJournal of Diabetes and its Complications
researchProduct

Effects of dynamic exercise and metabolic control on left ventricular performance in insulin-dependent diabetes mellitus

1987

In subclinical diabetic cardiomyopathy, previous reports did not positively correlate the altered cardiac performance with metabolic parameters. Fifteen insulin-dependent diabetic subjects, without any clinical or instrumental evidence of heart diseases, were studied. Signs of diabetic microangiopathy were absent. Systolic time intervals, metabolic and hormonal parameters (blood glucose, free fatty acids, blood lactate and plasma norepinephrine) were evaluated at rest and after dynamic exercise during poor (MAGE 6.36 +/- 0.72 mmol/l) and good (MAGE 3.46 +/- 0.66 mmol/l) metabolic control, obtained by means of insulin therapy. Rest values of systolic time intervals were normal during poor an…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPhysical ExertionLeft Ventricular Ejection TimeNorepinephrine (medication)EndocrinologyDiabetes mellitusDiabetic cardiomyopathyInternal medicineInternal MedicinemedicineHumansSubclinical infectionbusiness.industryInsulinHemodynamicsHeartGeneral Medicinemedicine.diseaseDiabetes Mellitus Type 1EndocrinologyMetabolic control analysisHeart Function TestsCardiologyFemalebusinessmedicine.drugHormoneActa Diabetologica Latina
researchProduct

Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.

2020

Background and aims: CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2–5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function. Methods and results: All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. LVH was observed in 62.8% of patients with CKD and in 51.9% of essential hypertensive patients (P < 0.0001). We found increasingl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationMedicine (miscellaneous)030209 endocrinology & metabolismBlood Pressure030204 cardiovascular system & hematologyurologic and male genital diseasesLeft ventricular hypertrophyRisk AssessmentVentricular Function Left03 medical and health sciencesNormal renal functionYoung Adult0302 clinical medicineInternal medicinePrevalenceMedicineHumansLeft ventricular geometryIn patientcardiovascular diseasesStage (cooking)Renal Insufficiency ChroniceducationDialysisAgededucation.field_of_studyNutrition and DieteticsVentricular Remodelingbusiness.industryMiddle Agedmedicine.diseaseCKD Echocardiography Hypertension Letf ventricular hypertrophy Ventricular geometryCross-Sectional StudiesItalyHeart Disease Risk FactorsHypertensionCardiologyFemaleHypertrophy Left VentricularEssential HypertensionCardiology and Cardiovascular MedicinebusinessKidney diseaseNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy

1993

The aim of this work was to study the insulin-like growth factor 1 (IGF1), a substance able to promote cell proliferation in vascular smooth muscle, in patients with mild-to-moderate hypertension and to analyse its relationship to sodium-lithium countertransport, a genetic marker of hypertension that is related to cardiovascular complications.We studied 32 hypertensive subjects, some with left ventricular hypertrophy, and 14 healthy subjects. Fasting plasma IGF1 was measured by means of a radioimmunoassay after octadecylsilica chromatography and Na(+)-Li+ countertransport was determined by the method of Canessa.Hypertensive patients had higher values of both IGF1 and Na(+)-Li+ countertransp…

AdultMalemedicine.medical_specialtyErythrocytesVascular smooth muscleLithium (medication)Heart diseasePhysiologymedicine.medical_treatmentEssential hypertensionLeft ventricular hypertrophyAntiportersMuscle hypertrophyInsulin-like growth factorReference ValuesInternal medicineInternal MedicineHumansMedicineInsulin-Like Growth Factor Ibusiness.industryGrowth factorMiddle Agedmedicine.diseaseEndocrinologyHypertensionFemaleHypertrophy Left VentricularCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Left ventricular Myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis.

2018

[EN] Background: Diagnostic Task Force Criteria (TFC) for arrhythmogenic cardiomyopathy (AC) exhibit poor performance for left dominant forms. TFC only include right ventricular (RV) dysfunction (akinesia, dyssynchrony, volumes and ejection fraction). Moreover, cardiac magnetic resonance imaging (CMRI) assessment of left ventricular (LV) dyssynchrony has hitherto not been described. Thus, we aimed to comprehensively characterize LVCMRI behavior in AC patients. Methods: Thirty-five AC patients with LV involvement and twenty-three non-affected family members (controls) were enrolled. Feature-tracking analysis was applied to cine CMRI to assess LV ejection fraction (LVEF), LV end-systolic and …

AdultMalemedicine.medical_specialtyHeart VentriclesCardiomyopathyMagnetic Resonance Imaging Cine030204 cardiovascular system & hematologyVentricular Function LeftStrainTECNOLOGIA ELECTRONICA03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineCardiac magnetic resonance imagingDiastoleInternal medicinemedicineLate gadolinium enhancementHumansCor030212 general & internal medicineLeft ventricular involvementVentricular dysfunctionCardiac magnetic resonance imagingArrhythmogenic Right Ventricular DysplasiaEjection fractionmedicine.diagnostic_testTask forcebusiness.industryLeft ventricular arrhythmogenic cardiomyopathyReproducibility of ResultsStroke VolumeMiddle Agedmedicine.diseasePatologiaDyssynchronyLv dyssynchronyCardiologyFemaleCardiology and Cardiovascular MedicineLEFT DOMINANTbusiness
researchProduct

Relation of endocrine and cardiac findings in acromegalics

1992

Cardiac involvement in 32 acromegalics was related to endocrine parameters, clinical score and duration of the disease as well as compared to that of 50 controls free of cardiac disease. Stress ECG, 24h Holter monitoring and echocardiography revealed that supraventricular premature complexes did not occur more often in acromegalics than in controls, both prevalence and severity of ventricular arrhythmia, however, were higher in patients compared to controls: 15/32 (48%) acromegalics had complex ventricular arrhythmia as compared with 6/50 (12%) normal subjects (p less than 0.01). Repetitive ventricular arrhythmia was manifest in 10/32 (31%) patients but only in 4/50 (8%) controls (p less th…

AdultMalemedicine.medical_specialtyHeart diseaseAdenomaEndocrinology Diabetes and MetabolismConcentric hypertrophyCardiomegalyLeft ventricular hypertrophySeverity of Illness IndexElectrocardiographyEndocrinologyInternal medicineAcromegalyPrevalenceHumansMedicinecardiovascular diseasesPathologicalAgedbusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseCircadian RhythmEndocrinologyGrowth HormoneAcromegalycardiovascular systemCardiologyFemalebusinessComplicationHormoneJournal of Endocrinological Investigation
researchProduct

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

2007

Aims Anderson–Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients. Methods and results Clinical and laboratory data were available in 714 patients from 11 countries (mean age 35 ± 17 years, 369 women, 336 treated). The prevalence of angina was 23 vs. 22%; palpitations and arrhythmias 27 vs. 26%; exertional dyspnoea 23 vs. 23%; and syncope 2 vs. 4%, in wom…

AdultMalemedicine.medical_specialtyHeart diseaseHeart DiseasesCardiomyopathyLeft ventricular hypertrophySyncopeAnginaRisk FactorsInternal medicinemedicinePalpitationsPrevalenceHumansVascular diseasebusiness.industryEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryEuropeIsoenzymesDyspneaTreatment OutcomeEchocardiographyalpha-GalactosidaseFabry DiseaseFemaleHypertrophy Left Ventricularmedicine.symptomCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateEuropean heart journal
researchProduct

Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.

2001

Left ventricular hypertrophy (LVH) in hypertensive subjects is associated with an increased prevalence of ventricular arrhythmias. To evaluate the effect of antihypertensive treatment on cardiac arrhythmias (CA) and transient episodes of myocardial ischemia (TEMI), we studied 46 hypertensive patients with LVH, divided into four groups randomly treated with enalapril, hydrochlorothiazide (HCTZ), atenolol, or verapamil (SR-V) for 6 months. Office blood pressure and office heart rate values were recorded, in basal conditions, after 1 and 6 months of treatment, and all patients underwent echocardiography, electrocardiographic Holter monitoring, and stress testing. All drugs significantly lowere…

AdultMalemedicine.medical_specialtyHeart diseaseMyocardial IschemiaBlood PressureLeft ventricular hypertrophyHydrochlorothiazideEnalaprilInternal medicineHeart rateInternal MedicinemedicineHumanscardiovascular diseasesEnalaprilAntihypertensive AgentsAgedmedicine.diagnostic_testbusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseAtenololBlood pressureHydrochlorothiazideTreatment OutcomeAtenololVerapamilHypertensioncardiovascular systemCardiologyElectrocardiography AmbulatoryFemaleHypertrophy Left VentricularbusinessElectrocardiographyAnti-Arrhythmia Agentsmedicine.drugAmerican journal of hypertension
researchProduct